The Journal of Hip Surgery 2019; 03(01): 002-007
DOI: 10.1055/s-0039-1681021
Special Section Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chondroblastoma of the Femoral Head: A Case Series and Literature Review

Tyler Hoskins
1  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Morristown Medical Center, Morristown, New Jersey
,
Laura Sonnylal
2  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Hackensack University Medical Center, Hackensack, New Jersey
,
Ian O'Connor
3  Georgetown University School of Medicine, Georgetown University, Washington, District of Columbia
,
Jay N. Patel
1  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Morristown Medical Center, Morristown, New Jersey
,
Kimona Issa
4  The Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
,
James C. Wittig
1  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Morristown Medical Center, Morristown, New Jersey
› Author Affiliations
Further Information

Publication History

10 September 2018

19 December 2018

Publication Date:
08 March 2019 (online)

Abstract

Chondroblastoma is a rare bone tumor predominantly affecting patients during the first and second decades of life. The purpose of this case series is to assist clinicians in establishing a proper diagnosis and treatment method for patients presenting with chondroblastoma of the femoral head. Symptoms of this tumor in the hip joint can be nonspecific, resulting in the critical delay of a proper diagnosis. Due to the aggressive nature of this tumor, an early diagnosis is vital to prevent significant local bone destruction and the potential loss of a mobile hip. The authors present a series of three adolescent patients treated by the primary investigator between 2014 and 2017 for chondroblastoma of the femoral head to help illustrate several diagnostic and treatment principles and considerations for clinicians. The mean Musculoskeletal Tumor Society score at the latest follow-up was 26 points (range: 25–27). No local recurrence was reported in any patient and all individuals have returned to preoperative function, and are participating in daily activities and sports.